- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03534427
The Effects of a Jump Rope Exercise Program on Vascular Health, Inflammatory Markers in Prehypertensive Adolescent Girls
October 27, 2020 updated by: Won-mok son, Pusan National University
The Effects of a 12-Week Jump Rope Exercise Training Program on Arterial Stiffness, Vasodilating and Vasoconstricting Factors, Inflammatory Markers, and Body Composition in Prehypertensive Adolescent Girls
The purpose of this study was to examine the impact of a 12-week jump rope exercise program on blood pressure, arterial stiffness, vasodilating and vasoconstricting factors, inflammatory markers, and body composition in prehypertensive adolescent girls.
Forty prehypertensive adolescent girls participated in this study.
The girls were randomly divided into the jump rope exercise intervention group (EX, n=20) and control group (CON, n=20).
The EX group performed a jump rope training program at 40-70% of their heart rate reserve (HRR) 5 days/week for 12 weeks (sessions 50 minutes in duration).
The CON group did not participate in any structured or unstructured exercise protocol.
Blood pressure, arterial stiffness, plasma nitrate/nitrite levels, endothelin-1, C-reactive protein, and body composition were measured before and after the 12-weeks study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- prehypertensive
- sedentary (no regular exercise training or physical activity within the last year)
- no weight loss diet during the last six months
Exclusion Criteria:
- pregnancy
- chronic disease
- daily medication use (including antioxidants and weight loss supplements)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
No exercise intervention
|
|
|
Experimental: Jump rope exercise intervention
The jump rope exercise program was performed for 50 minutes with 5 minutes of warm-up and cool-down per day, 5 times a week for 12 weeks.
The program consisted of various main jump rope exercises (1 line 2 jump, jumping feet together, running jumping, open side jump, open back and forth jump, rock paper scissor jump).
The warm-up and cool down consisted of static stretching, walking, and jogging.
Intensity of exercise was gradually increased from 40-50% heart rate reserve (HRR) in weeks 1-4 and to 60-70% HRR in weeks 9-12.
Each training session was supervised by the researchers.
Every subject wore a heart rate monitor during the whole training session in order to maintain the designated training intensity.
|
12-week jump rope exercise program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diastolic Blood Pressure
Time Frame: 12 weeks
|
12 weeks
|
|
|
Arterial Stiffness
Time Frame: 12 weeks
|
Arterial stiffness was measured as measurement of brachial to ankle pulse-wave velocity.
This indicates peripheral arterial stiffness, as it measures how quickly a pulse wave propagates from one point to another.
|
12 weeks
|
|
Endothelin-1
Time Frame: 12 weeks
|
Levels of Endothelin-1 in blood were measured by Endothelin-1 enzyme immunoassay kit.
|
12 weeks
|
|
Body Mass
Time Frame: 12 weeks
|
Body mass was measured to nearest 0.1 kg.
|
12 weeks
|
|
Height
Time Frame: 12 weeks
|
Height was measured to nearest 1 cm.
|
12 weeks
|
|
Waist Circumference
Time Frame: 12 weeks
|
Waist circumference was measured at midpoint between the lower rib and the iliac crest at the end of a normal expiration using a tape measure.
|
12 weeks
|
|
Body Fat
Time Frame: 12 weeks
|
Percent body fat (%) was determined using a bioelectrical impedance-meter.
|
12 weeks
|
|
Lean Body Mass
Time Frame: 12 weeks
|
Lean body mass (kg) was determined using a bioelectrical impedance-meter.
|
12 weeks
|
|
Nitrate/Nitrite Levels
Time Frame: 12 weeks
|
Nitrate and nitrite levels were assayed using a Griess assay kit.
|
12 weeks
|
|
C-reactive Protein
Time Frame: 12 weeks
|
C-reactive protein was assessed using an enzyme immunoassay assay kit
|
12 weeks
|
|
Systolic Blood Pressure
Time Frame: 12 weeks
|
Blood pressure was measured in duplicate using an automated sphygmomanometer.
The average of the two was recorded as the resting blood pressure.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 5, 2011
Primary Completion (Actual)
February 10, 2012
Study Completion (Actual)
March 21, 2012
Study Registration Dates
First Submitted
May 11, 2018
First Submitted That Met QC Criteria
May 11, 2018
First Posted (Actual)
May 23, 2018
Study Record Updates
Last Update Posted (Actual)
October 29, 2020
Last Update Submitted That Met QC Criteria
October 27, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PusanNU1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prehypertension
-
Liaquat University of Medical & Health SciencesUniversity of Rome Tor VergataNot yet recruitingHypertension | PrehypertensionItaly
-
University of LjubljanaRecruitingHealthy | Prehypertension (Elevated Blood Pressure) or HypertensionSlovenia
-
Foundation University IslamabadRecruiting
-
University of HartfordRecruitingPre Hypertension | Hypertension (HTN)United States
-
Rockefeller UniversityCompleted
-
LycoRed Ltd.Maccabi Healthcare Services, IsraelCompletedPrehypertensionIsrael
-
Zhiming ZhuCompletedPrehypertensionChina
-
University of AberdeenBiotechnology and Biological Sciences Research Council; Unilever R&DCompletedPrehypertensionUnited Kingdom
-
KGK Science Inc.Marealis ASCompletedPrehypertensionCanada, United States, Czech Republic, Germany
Clinical Trials on Jump rope exercise intervention
-
Riphah International UniversityCompleted
-
Karabuk UniversityActive, not recruitingPerformance | Training | Volleyball | Technical SkillsTurkey
-
Pusan National UniversityUniversity of Nebraska; Chonnam National UniversityCompletedPrehypertension | Blood Pressure | Adiposity | Insulin Sensitivity | Self Efficacy | Abdominal Obesity
-
University of AmericasCompletedEvaluation of the Effects of Weighted Jump Rope Training on the Isokinetic Shoulder Profile in CrossFit PractitionersChile
-
University College CopenhagenUniversity of Copenhagen; UCL University College, DenmarkRecruitingAcademic PerformanceDenmark
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulCompleted
-
Istinye UniversityCompletedPhysical Fitness | Health Young IndividualsTurkey (Türkiye)
-
University Hospital, MontpellierNot yet recruitingIdentification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk (TENVOL)Knee Injuries | Jumper's Knee | Patellar Tendinitis | Musculoskeletal InjuriesFrance
-
VA Office of Research and DevelopmentRecruitingMobility Impairment | Asymptomatic Carotid Stenosis (50-69%)United States